Loading…
Parmax Pharma (BSE 540359)₹133.70−1.00%Pharmaceuticals
At the end of the Jun 2026 quarter, Parmax Pharma's shareholders were: promoters 30.76%, public 69.24%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 2,272 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 30.76% | 30.76% | 30.79% | 30.76% | 30.76% | 30.76% | 30.76% | 30.76% | 30.76% | 30.76% | 30.76% | 30.76% |
| Public | 69.24% | 69.24% | 69.21% | 69.24% | 69.24% | 69.24% | 69.24% | 69.24% | 69.24% | 69.24% | 69.24% | 69.24% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 1,972 | 2,001 | 2,098 | 2,184 | 2,245 | 2,333 | 2,355 | 2,376 | 2,398 | 2,392 | 2,387 | 2,272 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Alkesh Mahasukhlal Gopani | Promoter | 17.98% | 0.00 |
| Vipul Mahasukhlal Gopani | Promoter | 12.82% | 0.00 |
| Gosalia Meena Alkesh | Public | 12.70% | 0.00 |
| Abhay Chinubhai Shah | Public | 6.60% | New |
| Umang Alkesh Gosalia | Public | 5.34% | 0.00 |
| Gosalia Nimit P | Public | 2.39% | −0.01 |
| Rupa Sunil Shah | Public | 1.44% | New |
| Pravina Mahasukhlal Gopani | Promoter | 0.02% | 0.00 |
| Pradeep Ramniklal Gosalia | Public | Exited | — |
| Bharti Deepak Mehta | Public | Exited | — |
| Vandana Pradeepbhai Gosalia | Public | Exited | — |
Promoters held 30.76% of Parmax Pharma at the end of the Jun 2026 quarter, the same as a year earlier.
No. The Jun 2026 filing shows no pledged promoter shares.
Parmax Pharma had 2,272 shareholders at the end of the Jun 2026 quarter, against 2,376 a year earlier.
Gosalia Meena Alkesh (Public) held 12.70% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.